Article

How do we treat local recurrence of breast cancer?

Author(s):

Debu Tripathy

On the third day of SABCS, one study gave us another answer on how to treat local recurrence of breast cancer. We also learn more about the role of radiation in breast cancer treatment. View the video below to get more insight into these breast cancer studies presented at the San Antonio Breast Cancer Symposium.

Related Videos
Registered nurse Patricia Jakel emphasizes the importance of educating patients on evolving breast cancer research and the need for routine screenings.
Dr. Debu Tripathy highlights the importance of staying informed on breast cancer advancements and how this empowers patients to make informed decisions.
Image od grey haired Doctor.
Antibody-drug conjugates have had a tremendous impact on breast cancer care and treatment, according to Dr. Charles E. Geyer.
Dr. Emre Yekedüz highlighted strategies that may improve patients' quality of life and mitigate treatment-related side effects in renal cell carcinoma.
Image of man with grey hair.
Image of man with black hair.
Image of doctor with grey hair.
Image of doctor with black hair.
Related Content
Illustartion of prostate.
March 21st 2025

First Patent Dosed With Pocenbrodib in Trial for Metastatic Prostate Cancer

Spencer Feldman
First patient dosed in phase 1b/2a trial for castration-resistant metastatic prostate cancer, evaluating pocenbrodib alone and with other drug combinations.
The Importance of Spotting Endometrial Cancer
March 18th 2025

The Importance of Spotting Endometrial Cancer

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.
Woman with brown hair.
March 21st 2025

The Unseen Long-Term Effects After Follicular Lymphoma Treatment

Karen Cohn
Life after treatment for follicular lymphoma brings long-term physical and emotional challenges, including immune system impacts and lasting social effects.
ROS1+ Non-Small Cell Lung Cancer: Progress in Care
September 20th 2024

ROS1+ Non-Small Cell Lung Cancer: Progress in Care

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West Cancer Center and Research Institute and Director of the Lung Cancer Disease research group and is sponsored by Bristol Myers Squibb.
The FDA has approved the use of Gozellix, a PSMA-PET imaging agent, to help detect prostate cancer using gallium-68 gozetotide in PSMA-PET scans.
March 21st 2025

FDA Approves Gozellix for Advanced PSMA-PET Imaging in Prostate Cancer

Ryan Scott
The FDA has approved the use of Gozellix, a PSMA-PET imaging agent, to help detect prostate cancer using gallium-68 gozetotide in PSMA-PET scans.
Treat lung diseases | Organ and pills on blue background top view | Image Credit: ©9dreamstudio - Adobe Stock
March 21st 2025

Understanding NCCN Guidelines: Gavreto in First-Line RET Fusion NSCLC

Spencer Feldman
Gavreto is recommended as a first-line treatment for metastatic RET fusion-positive, metastatic non-small cell lung cancer, with potential severe side effects.